Transgene-derived hepatocyte growth factor attenuates reactive renal fibrosis in aristolochic acid nephrotoxicity

Nephrology Dialysis Transplantation

Volumn 18, Issue 12, 2003, Pages 2515-2523

  Okada, Hirokazu ^a   Watanabe, Yusuke ^a   Inoue, Tsutomu ^a   Kobayashi, Tatsuya ^a   Kanno, Yoshihiko ^a   Shiota, Goshi ^b   Nakamura, Toshikazu ^c   Sugaya, Takeshi ^d   Fukamizu, Akiyoshi ^d   Suzuki, Hiromichi ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Aristolochic acid; Hepatocyte growth factor; Matrix metalloproteinase 9; Renal fibrosis; Tissue inhibitor of metalloproteinase 1

Indexed keywords

ANTIFIBROTIC AGENT; ARISTOLOCHIC ACID; EPIDERMAL GROWTH FACTOR; GELATINASE B; SCATTER FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL CULTURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; FIBROGENESIS; FIBROSING ALVEOLITIS; IN VITRO STUDY; KIDNEY FIBROSIS; KIDNEY TUBULE CELL; MALE; MICROSCOPY; MOUSE; NEPHROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DEGENERATION; TISSUE REGENERATION; TRANSGENE; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; ARISTOLOCHIC ACIDS; FIBROSIS; GROWTH SUBSTANCES; HEPATOCYTE GROWTH FACTOR; KIDNEY; KIDNEY DISEASES; MICE; MODELS, ANIMAL; NOXAE; TRANSGENES;

EID: 10744231641     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg440     Document Type: Article

References (22)

1. Matsumoto K, Nakamura T. Hepatocyte growth factor: renotrophic role and potential therapeutic for renal disease. Kidney Int 2001; 59: 2023-2038
2. Kawaida K, Matsumoto K, Shimazu H, Nakamura T. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA 1994; 91: 4357-4361
3. Miller SB, Martin DR, Kissane J, Hammerman MR. Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am J Physiol 1994; 266: F129-F134
4. Mizuno S, Kurosawa T, Matsumoto K et al. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest 1998; 101: 1827-1834
5. Mizuno S, Matsumoto K, Nakamura T. Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney Int 2001; 59: 1304-1314
6. Vanherweghem JL, Depierreux M, Tielemans C et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993; 341: 387-391
7. Cosyns JP, Jadoul M, Squifflet JP et al. Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int 1994; 45: 1680-1688
8. Cosyns JP, Jadoul M, Squifflet JP, Wese F, De Strihou CY. Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis 1999; 133: 1011-1017
9. Nortier JL, Martinez MC, Schmeiser HH et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000; 342: 1686-1692
10. Stiborova M, Frei E, Breuer A, Bieler A, Schmeiser HH. Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy. Exp Toxic Pathol 1999; 51: 421-427
11. Chen HY, Ma BY, Grant A, Lampert N. Time to abandon the term 'Chinese herbs nephropathy'. Kidney Int 2001; 60: 2039-2040
12. Shiota G, Wang T, Nakamura T, Schmidt EV. Hepatocyte growth factor in transgemic mice: effects on hepatocyte growth, liver regeneration and gene expression. Hepatology 1994; 19: 962-972
13. Igawa T, Matsumoto K, Kanda S, Saito Y, Nakamura T. Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am J Physiol 1993; 265: F61-F69
14. Takayama H, LaRochelle WJ, Sabnis SG, Otsuka T, Merlino G. Renal tubular hyperplasia, polycystic disease, and glomerulosclerosis in transgenic mice overexpressing hepatocyte growth factor/scatter factor. Lab Invest 1997; 77: 131-138
15. Takaya K, Koya D, Isono M et al. Involvement of ERK pathway in albumin-induced MCP-1 expression in mouse proximal tubular cells. Am J Physiol 2003; 284: F1037-F1045
16. Okada H, Ban S, Nagao S et al. Progressive renal fibrosis in murine polycystic kidney disease: an immunohistochemical observation. Kidney Int 2000; 58: 587-597
17. Okada H, Inoue T, Kanno Y et al. Renal interstitial fibroblast-like cells in Goodpasture syndrome rats. Kidney Int 2001; 60: 597-606
18. Okada H, Moriwaki K, Kalluri R et al. Osteopontin expressed by renal tubular epithelium mediates interstitial monocyte infiltration. Am J Physiol 2000; 278: F110-F121
19. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 2000; 15: 290-301
20. Liu Y, Rajur K, Tolbert E, Dworkin LD. Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways. Kidney Int 2000; 58: 2028-2043
21. Cosyns JP, Dehoux JP, Guiot Y et al. Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? Kidney Int 2001; 59: 2164-2173
22. Debelle FD, Nortier JL, De Prez EG et al. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J Am Soc Nephrol 2002; 13: 431-436